Copyright
©The Author(s) 2021.
World J Diabetes. Aug 15, 2021; 12(8): 1146-1163
Published online Aug 15, 2021. doi: 10.4239/wjd.v12.i8.1146
Published online Aug 15, 2021. doi: 10.4239/wjd.v12.i8.1146
Name | Model | Key findings | Ref. |
Pumpkin polysaccharide | HFD (mice) | Increases SCFAs production; selectively enhances the abundance of Bilophila and Prevotella | Liu et al[118] |
Inulin | T2DM in rats induced by HFD and streptozotocin and clinic trial | Increases SCFA-producing bacteria including Lachnospiraceae, Phascolarctobacterium, Bacteroides, and Akkermansia muciniphila | Li et al[112] and Food and Drug Administration, HHS[113] |
Lessonia nigrescens ethanolic extract | T2DM mice (streptozotocin injection) | Increases the ratio of Bacteroidetes/Firmicutes in the intestine | El Kaoutari et al[115] |
Grape pomace extract | HFD (mice) | Reduces the abundance of Desulfovibrio and Lactococcus, and increases the abundance of Allobaculum and Roseburia; improves the gut barrier function | Bowey et al[123] |
Resveratrol | NASH rat model | Ameliorates the intestinal barrier dysfunction and inflammation | Li et al[124] |
Quercetin | HFD (mice) | Reverts gut microbiota imbalance and related endotoxemia-mediated TLR4 pathway induction | Solon-Biet et al[61] |
Berberine | db/db mice High fat diet (mice and rats) FXR knockout (FXRint-/-) mice | Modulates the ratio of Firmicutes/Bacteroidetes; increases SCFA content in feces; regulates BCAAs biosynthesis and catabolism in liver and adipose tissue; reduces the increased expressions of inflammatory mediators and alleviates gut permeability by decreasing LPS level in plasma; modulates the bile acid cycle and subsequently the ileal FXR signaling pathway | Tesar and Kottke[129], He et al[130], Song et al[131], Wang et al[132], and Zhang et al[133] |
Capsaicin | ob/ob mice | Increases the ratio of Firmicutes to Bacteroidetes and the number of Roseburia; decreases the levels of proinflammatory cytokines, including TNF-α and IL-6 | Christodoulou et al[128] |
- Citation: Xia F, Wen LP, Ge BC, Li YX, Li FP, Zhou BJ. Gut microbiota as a target for prevention and treatment of type 2 diabetes: Mechanisms and dietary natural products. World J Diabetes 2021; 12(8): 1146-1163
- URL: https://www.wjgnet.com/1948-9358/full/v12/i8/1146.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i8.1146